Roundtable discussion: how lessons learned from HIV can inform the global response to viral hepatitis

BMC Infectious Diseases

Roundtable

Jens Lundgren¹  Jeffrey V Lazarus¹  John Peter Kools²  Katrin Schiffer²  Eberhard Schatz²  Jason Farell²  Catharina Matheï³  Maria Prins⁴  Jordi Casabona⁵  Margaret Walker⁶  Lilyana Chavdarova⁶  Paul Griffiths⁷  Lucas Wiessing⁷  Isabelle Giraudon⁷  Marica Ferri⁷  Luís Mendão⁸  Mirjam Kretzschmar⁹  Magdalena Harris^1,10  Peter Vickerman^1,11  Maria Kantzanou^1,12 

[1] CHIP, Centre for Health and Infectious Disease Research and WHO Collaborating Centre on HIV and Viral Hepatitis, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark;Correlation – European Network Social Inclusion and Health, Amsterdam, the Netherlands;Department of Public Health and Primary Care, KU Leuven, Leuven, Belgium;Department of Research, Public Health Service, Cluster Infectious Diseases, Amsterdam, the Netherlands;Center for Infection and Immunity (CINIMA), Academic Medical Center, Amsterdam, the Netherlands;Epidemiological Center for HIV/AIDS/STI of Catalonia (CEEISCAT), Barcelona, Spain;European Liver Patients’ Associaton, B-3800 Sint-Truiden, Belgium;European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Lisbon, Portugal;G.A.T. – Grupo Português de Activistas sobre Tratamentos de VIH/SIDA – Pedro Santos, Portugal;European AIDS Treatment Group, B-1050 Brussels, Belgium;Julius Centre for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht, the Netherlands;Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands;London School of Hygiene and Tropical Medicine (LSHTM), London, UK;London School of Hygiene and Tropical Medicine (LSHTM), London, UK;School of Social and Community Medicine, University of Bristol, Bristol, UK;National Reference Centre for Retroviruses, Laboratory of Hygiene, Epidemiology and Medical Statistics, University of Athens Medical School, Athens, Greece;

关键词: Hepatitis;    Viral Hepatitis;    Harm Reduction;    Public Health Response;    Opioid Substitution Therapy;   

DOI  :  10.1186/1471-2334-14-S6-S18

来源: Springer

【 授权许可】

CC BY   
© Lazarus et al; licensee BioMed Central Ltd. 2014